Novita Capital

Eric Fullmer, the firm's founder, acts as Managing Director and is the central decision-maker. Each operating company also maintains a dedicated cofounder or director — such as Roberto Herrera at Hospital Metropolitano or Martí Jiménez at Verdeza — who leads that entity's strategy within Novita's portfolio.

Novita functions as an originating operator: it identifies structural gaps in Central American services — particularly healthcare and housing — then assembles management teams, sites, and regulatory approvals to build companies de novo. The firm's three-year site-selection process for Verdeza exemplifies the deliberate, ground-up sourcing model.

Novita only pursues direct deals. The firm does not report any fund-of-funds commitments or investments in externally managed vehicles. Every disclosed holding — from Hospital Metropolitano to the planned Residential REIT — was created and capitalized directly by Novita.

Novita's public materials do not list specific exclusions. However, its disclosed portfolio shows a deliberate concentration in healthcare services and real estate, with a single consumer products line (Berkana Naturals). Traditional tech venture and financial services are notably absent from its holdings.

Novita launched Hospital Metropolitano in 2010 and later established MediSmart as the health management organization serving its patient base. The two entities operate as sister companies, with Novita providing the originating capital and strategic oversight (per the firm).